Integrative Sexual Health

Author(s):  
Andrew Weil

Integrative Sexual Health explores beyond the standard topics in men’s and women’s health, drawing on a very rich and diverse research literature. Books on sexuality typically are for the clinical specialist and cite only focally relevant research, or are geared to lay knowledge and cite almost no research. Integrative Sexual Health provides an overview of sexual biology and sexual dysfunction, diverse lifespan, lifestyle, and environmental impacts on sexual function, applies complementary and integrative medicine solutions to sexual problems, and offers traditional Eastern and Western treatment approaches to resolving sexual difficulties. Written by diverse integratively trained experts in sexuality, psychology, psychiatry, and other medical specialties. Integrative Sexual Health includes clinical vignettes, detailed treatment strategies for mitigating the side effects of medications, and sexual dysfunction associated with medical illness and poor lifestyle habits, as well as citing extensive research and further resources. Integrative treatment modalities not typically consulted in mainstream sexual medicine, such as traditional Chinese medicine, Ayurvedic medicine, aromatherapy, and botanical medicine are presented with the best available evidence, in a clinically relevant manner. This volume in the Weil Integrative Medicine Library will be valuable to the specialist and non-specialist alike, who seek to understand and treat sexual problems using an integrative medicine approach, and acquire tools to help patients maintain lifetime optimal general health and vitality that supports healthy sexuality.

Author(s):  
Benjamin Mills ◽  
Indiran Govender ◽  
Jannie Hugo

Background: Sexual problems are common. Many patients with sexual health dysfunction use self-help literature or are often managed in general practice. However, many general practitioners (GPs) find it difficult to discuss sexual health issues because they feel uncomfortable with this and lack training in these matters. These GPs are now referring patients with sexual dysfunction to specialists.Aim: We sought to explore how GPs working in the Mabopane and Ga-Rankuwa areas of handle sexual problems of their patients.Setting: The setting was the Mabopane and Ga-Rankuwa areas of North-West Tshwane, in Gauteng Province.Methods: A qualitative study comprising eight free attitude interviews with purposefully selected four male and four female GPs. All interviews were conducted in English and tape-recorded. Field notes in the form of a detailed diary was kept. The tapes were transcribed verbatim, and the transcriptions were checked against the tapes for omissions and inaccuracies.Results: Six themes emerged from the interviews: causes of sexual problems; presentation of sexual problems to the doctor; management of sexual health problems; sex is a taboo topic; society’s need for sexual health discussions, and these discussions have already begun; previous limited exposure and training, and a need for more sexual health training.Conclusion: This study confirms earlier findings that patients could be either reluctant to discuss their problems or are open about them when presenting to doctors with sexual dysfunction. GPs were not exposed to sexual health training at medical school and, because of this shortcoming, felt that training in sexual medicine should be part of the curriculum.


2019 ◽  
Vol 1 (2) ◽  
pp. 111-113
Author(s):  
Soumya Parameshwaran ◽  
Prabha S. Chandra

Female sexual dysfunction has always had challenges related to nosological issues due to inadequate research and understanding in this area. The ICD-11 has proposed substantial changes to the classification of conditions related to sexual health. In this review, we have discussed the proposed changes, compared with other classificatory systems and discussed its implications on clinical practice and research in this field. While there have been several progressive moves in the taxonomy of sexual dysfunctions, we have expressed our views on possible changes which can help with better diagnosis and management of sexual problems in women.


1999 ◽  
Vol 5 (2) ◽  
pp. 38 ◽  
Author(s):  
Bernadette Hood ◽  
Ronnie Egan ◽  
Heather Gridley ◽  
Christine Brew

A substantive quantitative research literature base exists exploring aspects of treatment for depression. Major themes to emerge from this literature include the use of general practitioners (GPs) in preference to psychiatrists for treatment and the negative public attitudes toward the use of pharmacological treatment strategies for depression. The study reported in this paper utilises a qualitative methodology to explore the experiences and attitudes of women currently being treated for depression. Specifically the paper focusses on the women's attitudes toward psychological versus medical treatment options for the disorder. Attitudes toward treatment modalities of medical and non-medical primary service providers are also investigated. Several significant findings emerged from the study. Women interviewed expressed a sense of personal responsibility for both the occurrence and management of depression.Consequent to this belief psychosocial interventions were critical to 'getting well'. Medication was viewed positively by all women, not as a treatment for depression, rather as a means of relieving the extreme symptoms of the illness, therefore providing space for psychosocial interventions. Medical and non-medical service providers expressed an acceptance of the need for integrating psychological and pharmacological treatment strategies though all providers acknowledged their lack of skills in incorporating treatments outside of their professional training. The study provides insight into the belief structures which influence participants' behaviours, presenting a less polarised view of attitudes toward psychological and pharmacological interventions than suggested by the current quantitative literature.


2003 ◽  
Vol 37 (4) ◽  
pp. 546-555 ◽  
Author(s):  
Kelly R Ragucci ◽  
Nicole S Culhane

OBJECTIVE: To review the pathophysiology and psychology of female sexual dysfunction (FSD) and describe potential prevention and treatment strategies for the disorder. DATA SOURCES: Articles identified from a MEDLINE search (1966–June 2002) using the term female sexual dysfunction. Additional references were obtained from cross referencing retrieved articles. STUDY SELECTION AND DATA EXTRACTION: After evaluating various review articles, clinical trials, and investigational studies, all information that was deemed relevant by the reviewers was included. DATA SYNTHESIS: FSD is a multicausal and multidimensional problem combining biological, psychological, and interpersonal factors. The American Foundation for Urological Disease classifies FSD into 4 broad categories: sexual desire disorders, arousal disorder, orgasmic disorder, and sexual pain disorders. Depending on specific individual characteristics and category of disorder, a variety of potential treatments are available. Pharmacists can play a role in identifying and managing medication-related adverse effects that may be exacerbating FSD and educating women on treatment modalities. CONCLUSIONS: FSD is a complicated disorder that is often difficult to identify, classify, and treat appropriately. Pharmacists should have an understanding of the potential causes of FSD and the treatment options available so that they may make appropriate recommendations and counsel women effectively.


1998 ◽  
Vol 1 (2) ◽  
pp. 83-87 ◽  
Author(s):  
Meeking ◽  
Fosbury ◽  
Cummings ◽  
Alexander ◽  
Shaw ◽  
...  

2009 ◽  
Vol 5 (2) ◽  
pp. 81 ◽  
Author(s):  
Martijn WA van Geldorp ◽  
Johanna JM Takkenberg ◽  
Ad JJC Bogers ◽  
A Pieter Kappetein ◽  
◽  
...  

Over the next few decades the number of patients diagnosed with aortic stenosis is expected to rise as the population ages and the use of several diagnostic tools expands. This will result in a growing need for both medical and surgical treatment and stimulate the development of new diagnostic and surgical techniques. This article briefly describes the prevalence, pathogenesis and clinical presentation of patients with aortic stenosis and focuses on developments in diagnostic tools, treatment strategies and treatment modalities: the use of echocardiography, tissue Doppler imaging, stress testing and biomarkers is discussed, as well as timing of surgery and the role microsimulation can play in prosthesis selection. Furthermore, newly developed transcatheter valve implantation techniques and their possible role in treating ‘inoperable’ or ‘elderly’ patients are discussed.


Author(s):  
Tahereh Molkara ◽  
Maliheh Motavasselian ◽  
Farideh Akhlaghi ◽  
Mohammad Arash Ramezani ◽  
Hamideh Naghedi Baghdar ◽  
...  

: Sexual health plays an important role in the women’s health and quality of life. Sexual health management is a prerequisite for physical and psychological health of women. Sexual desire, arousal, and orgasm are three factors of female sexual response. So far many different methods has been known for the treatment of female sexual dysfunction, however none of them are not an efficacious therapy. Generally, use of herbal medicine is a safe and effective therapeutic method in the treatment of women with sexual dysfunction. The role of herbal and nutritional supplementation in female sexual function has attracted researchers’ interest in recent years. This study aimed to the evaluation of the studies focusing on the herbal medicine on women sexual function and the assessment of its effectiveness.


2021 ◽  
Vol 10 (13) ◽  
pp. 2803
Author(s):  
Carolin Czauderna ◽  
Martha M. Kirstein ◽  
Hauke C. Tews ◽  
Arndt Vogel ◽  
Jens U. Marquardt

Cholangiocarcinomas (CCAs) are the second-most common primary liver cancers. CCAs represent a group of highly heterogeneous tumors classified based on anatomical localization into intra- (iCCA) and extrahepatic CCA (eCCA). In contrast to eCCA, the incidence of iCCA is increasing worldwide. Curative treatment strategies for all CCAs involve oncological resection followed by adjuvant chemotherapy in early stages, whereas chemotherapy is administered at advanced stages of disease. Due to late diagnosis, high recurrence rates, and limited treatment options, the prognosis of patients remains poor. Comprehensive molecular characterization has further revealed considerable heterogeneity and distinct prognostic and therapeutic traits for iCCA and eCCA, indicating that specific treatment modalities are required for different subclasses. Several druggable alterations and oncogenic drivers such as fibroblast growth factor receptor 2 gene fusions and hotspot mutations in isocitrate dehydrogenase 1 and 2 mutations have been identified. Specific inhibitors have demonstrated striking antitumor activity in affected subgroups of patients in phase II and III clinical trials. Thus, improved understanding of the molecular complexity has paved the way for precision oncological approaches. Here, we outline current advances in targeted treatments and immunotherapeutic approaches. In addition, we delineate future perspectives for different molecular subclasses that will improve the clinical care of iCCA patients.


Sign in / Sign up

Export Citation Format

Share Document